Experience with uterine balloon tamponade in postpartum hypotonic bleedings


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Subjects and methods. Group 1 included 35 puerperas who underwent standard therapy and UBT; Group 2 consisted of 49 patients who received a basic treatment protocol. Results and discussion. The UBT group showed significant (p < 0.05) reductions in the total volume of blood loss, in the frequency of surgical interventions, in the need for blood products, in the large doses of prostaglandins, in the large volumes of infusion therapy, antibacterial therapy, and painkillers. Breastfeeding started in 85% of cases within the first 2 hours. In addition, the levels of Hb and patient satisfaction with the treatment received were also significantly higher. Conclusion. UBT is consistent with the strategy for preserving the reproductive potential of women and makes it possible to significantly improve medico-economic indicators and to increase the level of satisfaction and the quality of life in women.

Full Text

Restricted Access

About the authors

Arsen Askerovich Askerov

Clinical Maternity Hospital Two

Email: askerov.arsen@inbox.ru
MD, Professor, Head of the Department of Obstetrics and Gynecology № 2; President of Obstetrician Gynecologists and Neonatologists Association of Kyrgyz Republic.

Saltanat Bolsunbekovna Nazaralieva

National Center for Maternal and Child Care

Email: saltanat.nazaralieva@gmail.com
PhD, Deputy Chief Physician for obstetrics and gynecology

Saikal Kamchybekovna Osmonova

National Center for Maternal and Child Care

Email: saikal.osmonova@gmail.com
Postgraduate, obstetrician-gynecologist

References

  1. Trends in maternal mortality: 1990 to 2015. Estimates by World Health Organization (WHO), United Nations Children’s Fund (UNICEF), United Nations Population Fund (UNFPA), World Bank Group, United Nations Population Division (UNPD). Geneva: WHO; 2015. Available at: http:// www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/en/ Accessed 13.04.2017.
  2. Alkema L., Chou D., Hogan D., Zhang S., Moller A.B., Gemmill A. et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016; 387(10017): 462-74. doi: 10.1016/S0140-6736(15)00838-7.
  3. Say L., Chou D., Gemmill A., Tunçalp Ö., Moller A.B., Daniels J. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Health. 2014; 2(6): e323-33. doi: 10.1016/S2214-109X(14)70227-X.
  4. Belfort M.A., Lokwood Ch.J., Barss V.A. Overview of postpartum hemorrhage. UpToDate, Inc.; 2015. Available at: http//www.uptodate.com/contents/ overview-of-postpartum-hemorrage#H1
  5. Ramanathan G., Arulkumaran S. Postpartum haemorrhage. Curr. Obstet. Gynaecol. 2006; 16(1): 6-13.
  6. Первый отчет конфиденциального аудита материнской смертности в Кыргызской Республике за 2011-2012 гг. Кыргызстан; 2014: 15-6.
  7. Knight M.; on behalf of UKOSS. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrage. BJOG. 2007; 114(11): 1380-7.
  8. Баев О.Р., Давыдов А.И. Послеродовое кровотечение: акушерская тактика и интенсивная терапия. Вопросы гинекологии, акушерства и перинатологии. - 2011; 10(6): 65-9.
  9. Doumouchtsis S.K., Papageorghiou A.T., Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to when medical treatment fails. Obstet. Gynecol. Surv. 2007; 62(8): 540-7.
  10. Olsen R., Reisner D.P., Benedetti T.J. Bakri balloon efectiveness for postpartum hemorrhage: a «real world experience». J. Matern. Fetal Neonatal Med. 2013; 26(17): 1720-3. doi: 10.3109/14767058.2013.796354.
  11. Lohano R., Haq G., Kazi S., Sheikh S. Intrauterine balloon tamponade for the control of postpartum haemorrhage. J. Pak. Med. Assoc. 2016; 66(1): 22-6.
  12. Vintejoux E., Ulrich D., Mousty E., Masia F., Marès P., de Tayrac R., Letouzey V. Success factors for Bakri™ balloon usage secondary to uterine atony: a retrospective, multicenter study. Aust. N. Z. J. Obstet. Gynaecol. 2015; 55(6): 572-7.
  13. Кукарская И.И. Управляемая баллонная тампонада матки при операции кесарева сечения как метод профилактики острой массивной кровопотери. Акушерство и гинекология. 2012; 7: 80-3.
  14. Клинические протоколы по акушерству-гинекологии для первичного, вторичного и третичного уровней здравоохранения: сб. № 3 / МЗ К.Р. Бишкек; 2010.
  15. Condous G.S., Arulkumaran S., Symonds I., Chapman R., Sinha A., Razvi K. The «tamponade test» in the management of massive postpartum hemorrhage. Obstet. Gynecol. 2003; 101(4): 767-72.
  16. Frenzel D., Condous G.S., Papageorghiou A.T., McWhinney N.A. The use of “tamponade test” to stop massive obstetric haemorrhage in placenta accreta. BJOG. 2005; 112(5): 676-7. doi: 10.11111/j.1471-0528.2005.00491.x.
  17. Royal Australian and New Zealand College of Obstetriciancs and Gynaecologists. Management of postpartum hemorrhage. March 2011. Accessed 11. 1. 2013.
  18. Chandraharan E., Arulkumaran S. Surgical aspects of postpartum haemorrage. Best Pract. Res. Clin. Obstet. Gynecol. 2008; 22(6): 1089-102. doi: 10.1016/j. bpobgyn.2008.08.001.
  19. Doumouchtsis S.K., Nikolopoulos K., Talaulikar V., Krishna A., Arulkumaran S. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG. 2014; 121(4): 382-8. doi: 10.1111/1471-0528.12546.
  20. O’Leary J.A. Uterine artery ligation in the control of postcesarean haemorrhage. J. Reprod. Med. 1995; 40(3): 189-93.
  21. Рымашевский А.Н., Радзинский В.Е., Красникова Н.А., Терехина Л.А., Лукаш А.И., Оленев А. С. Хирургический компонент лечения акушерских гипотонических кровотечений. Акушерство и гинекология. 2008; 3: 30-4.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies